Specifically, M2 macrophage-derived exosomes deliver miR-27a-3p to hemangioma stem cells, reducing their sensitivity to propranolol by targeting dickkopf-related protein 2 (DKK2). The gene discussed is DKK2; the disease is hemangioma.